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descriptors, VLife MDSAbstract TRPM8 is now best known as a cold- and menthol-activated channel implicated in ther-
mosensation. TRPM8 is speciﬁcally expressed in a subset of pain- and temperature-sensing neuron.
TRPM8 plays a major role in the sensation of cold and cooling substances. TRPM8 is a potential
new target for the treatment of painful conditions. Thus, TRPM8 antagonists represent a new,
novel and potentially useful treatment strategy to treat various disease states such as urological dis-
orders, asthma, COPD, prostate and colon cancers, and painful conditions related to cold, such as
cold allodynia and cold hyperalgesia. Better tools such as potent and speciﬁc TRPM8 antagonists
are mandatory as high unmet medical need for such progress. To achieve this objective quantitative
structure–activity relationship (QSAR) studies were carried out on a series of 25 benzimidazole-con-
taining TRPM8 antagonists to investigate the structural requirements of their inhibitory activity
against cTRPM8. The statistically signiﬁcant best 2D-QSAR model having correlation coefﬁcient
r2 = 0.88 and cross-validated squared correlation coefﬁcient q2 = 0.64 with external predictive
ability of pred_r2 = 0.69 was developed by SW-MLR. The physico-chemical descriptors such as
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found to show a signiﬁcant correlation with biological activity in benzimidazole derivatives. Molec-
ular ﬁeld analysis was used to construct the best 3D-QSAR model using SW-kNN method, showing
good correlative and predictive capabilities in terms of q2 = 0.81 and pred_r2 = 0.55. Developed
kNN-MFA model highlighted the importance of shape of the molecules, i.e., steric & electrostatic
descriptors at the grid points S_774 & E_1024 for TRPM8 receptor binding. These models (2D &
3D) were found to yield reliable clues for further optimization of benzimidazole derivatives in the
data set. The information rendered by 2D- and 3D-QSAR models may lead to a better understand-
ing of structural requirements of cTRPM8 antagonists and also can help in the design of novel
potent cTRPM8 antagonists.
ª 2012 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Temperature detection is essential for mammalian homeostasis
which dictates our responses to the environment. Several mem-
bers of the transient receptor potential (TRP) superfamily of
ion channels function as molecular transducers of thermal
stimuli (Sabnis et al., 2008). TRPM8 is a cold & menthol sens-
ing ion channel that acts by converting thermal & chemical
stimuli into neuronal signals and sensations of cooling/cold.
TRPM8 proteins have amino- and carboxyl-terminal intracel-
lular domains separated by a domain containing six transmem-
brane helices (S1–S6) in which the last two helices (S5 and S6)
ﬂank a loop, called the pore loop, which determines ion selec-
tivity (Tsavaler et al., 2001).
TRPM8 transcripts are expressed in a sub-population of
cold responsive primary afferent sensory neurons within the
dorsal root and trigeminal ganglia, as well as in normal prostate
and testicular tissues, and in taste papillae (Sabnis et al., 2008).
Later studies detected TRPM8 mRNA or protein (or both) in a
subset of sensory neurons from dorsal root ganglia and trigem-
inal ganglia, in nodose ganglion cells innervating the upper gut,
gastric fundus, vascular smooth muscle, liver and in bladder
urothelium and different tissues of the male genital tract (Voets
et al., 2007). Three novel natural odorants linalool, geraniol
and hydroxycitronellal that activate TRPM8, together with
the fact that TRPM8 is expressed in the trigeminus, which be-
longs to the sensory system of the olfactory epithelium, suggest
that TRPM8 could be an important ‘Chemosensory Trigeminal
Nerve Receptor’ (Behrendt et al., 2004).
Recent studies show that TRPM8 is expressed in non-neu-
ronal tissues like visceral organs and the sensory pathways
supplying them, particularly the urinary tract (Hayashi et al.,
2009; Zhao et al., 2010). Clinical trials using herbal remedies
containing peppermint attenuate symptoms of colonic hyper-
sensitivity, which manifests clinically in patients with irritable
bowel syndrome (IBS) as abdominal pain (Ford et al., 2008;
Merat et al., 2010). Studies in the tongue and skin indicate a
peripheral mechanism whereby TRPM8 activation evokes
antinociception attributed to the desensitization of TRPV1-
mediated responses (Klein et al., 2010). TRPM8 has the
following functions: Innocuous cold perception, behavioral
thermoregulation, cold-mediated analgesia; intense cold noci-
ception (Flockerzi, 2007).
TRPM8 is a non-selective voltage-gated cation channel per-
meable to both monovalent and divalent cations (McKemyet al., 2002; Peier et al., 2002) activated upon membrane depo-
larization, comparable to classical voltage-gated K+, Na+ and
Ca2+, but with a much weaker voltage sensitivity (Voets et al.,
2004). TRPM8 ion channel, upon activation allows entry of
Na+ & Ca2+ ions to the cells and leads to depolarization &
generation of action potential which eventually leads to sensa-
tion of cold (Sherkheli et al., 2007, 2008). Rohacs and col-
leagues proposed that Ca2+ inﬂux through TRPM8 leads to
activation of Ca2+-dependent phospholipase C (e.g. PLCd1),
leading to depletion of cellular PIP2 levels and channel desen-
sitization. They also provided evidence that positively charged
residues in the TRP domain, which is located C-terminal of
TM6, participate in the interaction of the channel with mem-
brane-bound PIP2 (Rohacs et al., 2005). Electrophysiological
studies have demonstrated that TRPM8 is expressed on the
plasma and the endoplasmic reticulum (ER) membranes of
cells, where it facilitates the inﬂux or release of Ca2+ from
the extracellular sources and the ER stores, respectively (Ma-
hieu et al., 2007).
Capsazepine, thio-BCTC [N-(4-tert butyl-phenyl)-4-(3-
chloropyridin-2-yl) tetrahydro-pyrazine-1(2H)-(thio)carbox-
amide] and BCTC [N-(4-tert.butyl-phenyl)-4-(3-chloropyri-
din-2-yl) tetrahydropyrazine-1(2H)-carboxamide] were found
to be antagonists of TRPM8. Studies in cell lines revealed that
TRPM8 is required for prostate cancer cell survival (Behrendt
et al., 2004). Prolonged activation of TRPM8 variant receptor
leads to enhanced production of various proinﬂammatory
cytokines, suggesting a role for this receptor in cellular inﬂam-
matory responses mediated by cold air/temperature. TRPM8
activation and its downstream response elements could pro-
vide potential new targets of drug development for cold-in-
duced respiratory diseases such as asthma (Sabnis, 2007). A
recent report provides intriguing evidence for a role of TRPM8
in bladder function. It was shown that ﬁlling of the bladder
with cold water induces a detrusor reﬂex and voiding in pa-
tients which states a role for TRPM8 in bladder function
(Tsukimi et al., 2005). Thus, novel TRPM 8 variant receptors
represent an attractive novel strategy to treat various disorders
such as asthma, COPD, cancer and so on.
Molecular modeling study is an approach used to narrow
down a library containing an extraordinarily high number of
random molecules into a smaller list of the potentially effective
inhibitors. The techniques of QSAR are valuable molecular
modeling tools for drug design (Jain et al., 2012a,b). The quan-
titative structure–activity relationship (QSAR) approach be-
Table 1 Structures of dataset used for MLR and kNN-MFA QSAR analysis with corresponding experimental activities against
cTRPM8 of benzimidazole derivatives.
N
N
H
R1
R2
Z
Compound R1 R2 Z cTRPM8 IC50 (nM) cTRPM8 pIC50
1b CF3 N
O
–H 61 7.21
2 CF3 O
N
–H 6.0 8.22
3 CF3 N O
–H 3.1 8.51
4 F
N O
–H 2.9 8.54
5 OCF3
N O
–H 1.1 8.96
6b OCHF2
N O
–H 2.5 8.6
7
O
O
F
F
N O
–H 91 7.04
8 Cl
N O
–H 2.4 8.62
9
CH3
CH3
OH
N O
–H 7.9 8.1
10b F
F
N O
–H 2.3 8.64
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Table 1 (continued)
Compound R1 R2 Z cTRPM8 IC50 (nM) cTRPM8 pIC50
11a,b CF3
F
N O
–H 0.6 9.22
12b OCF3
F
N O
–H 0.8 9.1
13b CF3 N O
–F 2.2 8.66
14b CF3 N O
–Cl 3.3 8.48
15a CF3 N O
–CN 0.7 9.15
16 CF3 N O
–Br 2.7 8.57
17 F N
O
–CF3 1.7 8.77
18 CF3 N O
–CF3 0.8 9.1
19a OCF3 N O
–CF3 1.2 8.92
20a Cl N
O
–CF3 1.0 9
21 CF3 N O
–(CH2)3OH 0.2 9.7
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Table 1 (continued)
Compound R1 R2 Z cTRPM8 IC50 (nM) cTRPM8 pIC50
22 CF3
N O
O
–H 6.7 8.17
23 CF3
N O
CF2
–H 0.9 9.05
24 CF3
N O
O
–CF3 1.4 8.85
25 CF3
N O
O
–Cl 4.0 8.4
a Indicates the compounds considered in the test set, rest of the compounds considered in the training set for 3D-QSAR study.
b Indicates the compounds considered in the test set, rest of the compounds considered in the training set for 2D-QSAR study.
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biological activities, particularly in drug design. This approach
is based on the assumption that the variations in the properties
of the compounds can be correlated with changes in their
molecular features (Jain et al., 2012c). The QSAR approach
helps to correlate the speciﬁc biological activities or physical
properties of a series of compounds with the measured or com-
puted molecular properties of the compounds, in terms of
descriptors (Hansch, 1969; Doweyko, 2008; Scior et al.,
2009). QSAR methodologies save resources and expedite the
process of the development of new molecules and drugs. Three
dimensional quantitative structure–activity relationship (3D-
QSAR) is widely used tool to identify the steric, electrostatic,
and hydrophobic structural requirements of various drugs act-
ing via receptor modulation for exerting biological activity. By
the application of 3D-QSAR models, the number of com-
pounds that need to be synthesized by a medicinal chemist
can be reduced greatly. Thus, the time and cost of drug discov-
ery and development can also be reduced (Bhadoriya et al.,
2012a,b; Gaurav et al., 2010).
To the best of our knowledge, till date such QSAR study
has not been reported on benzimidazole as cTRPM8 antag-
onists as discussed in this article. This inspired us to under-
take this work. This study is aimed to elucidate the
structural features of benzimidazole derivatives required for
antagonism of cTRPM8 and to obtain predictive 2D- and
3D-QSAR models to guide the rational synthesis of novel
antagonists. In this investigation, widely used technique,
viz. stepwise (SW) has been applied for descriptor optimiza-
tion, and MLR & kNN-MFA analyses have been applied
for 2D- and 3D-QSAR models development. The generated
models provide insight into the inﬂuence of various interac-
tive ﬁelds on the activity and, thus, can help in designing
and forecasting the inhibition activity of novel cTRPM8
antagonists.2. Materials and methods
All molecular modeling studies (2D and 3D-QSAR) were car-
ried out on a Windows XP workstation using the molecular
modeling software package VLife Molecular Design Suite
(VLife MDS) version 3.5 (VLife MDS 3.5, 2008).
2.1. Biological activity dataset for analysis
The 25 benzimidazole derivatives were selected for the dual 2D
and 3D-QSAR model development. The inhibitory activities
[IC50 (nM)] of benzimidazole derivatives against cTRPM8
have been studied by Parks et al. The in vitro inhibitory activ-
ity data against cTRPM8 of all 25 compounds were collected
from the literature (Parks et al., 2011). For QSAR analysis,
these biological activities [IC50 (nM)] were converted into
pIC50 values which were used as the dependent variable in
the model development. Table 1 shows the structure of 25 such
compounds along with their biological activity values.2.2. Computational details
The structures of all 25 compounds were drawn in Chem
sketch version 12.0 (ACD/Chemsketch 12.0, 2009). All struc-
tures were cleaned and 3D optimized. Geometry optimization
was carried out using Merck Molecular Force Field (MMFF)
(Halgren, 1996a–d, 1999a,b) with distance dependent dielectric
function and energy gradient of 0.001 kcal/mol A˚.2.3. Conformational analysis
Conformational analysis involves moving the atoms of a
molecule in such a way that the total energy of the system is
reduced based on an empirical representation of the interac-
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pounds were subjected to conformational analysis and energy
minimization using Monte Carlo conformational search with
RMS gradient of 0.001 kcal/mol using a MMFF. Monte Carlo
search method is a random search method for ﬁnding confor-
mations of molecules (Metropolis et al., 1953). It uses the
Metropolis condition to accept or discard generated conform-
ers. The conformers for all 25 optimized compounds were gen-
erated and selected the low energy conformer for each
compound and used for further study. The basis of energy
minimization is that the drug binds to effectors/receptors in
the most stable form, i.e., the minimum energy form.
2.4. Molecular modeling for 2D-QSAR
2.4.1. Calculation of 2D Molecular descriptors
The purpose of molecular descriptor is to calculate the proper-
ties of molecules that serve as numerical characterizations of
molecules in other calculations, such as QSAR, diversity anal-
ysis, and combinatorial library design. The energy-minimized
geometry was used for the calculation of the various 2D molec-
ular descriptors. A large number of theoretical 2D individual
descriptors such as Mol. Wt., Volume, XlogP, smr, polarizab-
ilityAHP; physicochemical such as kappa2, XcompDi-
pole,+vePotentialSurfaceArea, XKMostHydrophilic, Polar
Surface Area; alignment independent topological descriptors
such as T_T_O_2, T_T_T_O, T_T_N_6, T_T_T_1 type have
been computed for these geometrically optimized structures
from the chemical structures of the compounds referred to
above with a view to develop structure–activity relationship
of benzimidazole derivatives against cTRPM8. A total of 938
molecular descriptors were calculated for our present investi-
gation using VLife Sciences Molecular Design Suite and prior
to the 2D-QSAR model development, the set of calculated
molecular descriptors was reduced for further analysis. The
preprocessing of the independent variables (i.e., 2D descrip-
tors) was done by removing the invariable (constant column)
which resulted in a total of 235 molecular descriptors to be
used for QSAR analysis.
2.4.2. Training and test set selection
In order to obtain a validated 2D-QSARmodel for the purpose
of meaningful prediction, biological activity dataset should be
divided into the training and test sets. The sphere exclusion
method was adopted for division of training and test sets com-
prising 18 and 7 compounds, respectively. This approach re-
sulted in selection of compounds. 1, 6, 10, 11, 12, 13 and 14
as the test set for validating the quality of the models and the
remaining 18 compounds as the training set for generating
2D-QSAR models.
2.4.3. Variable selection and model development
Variable selection is a key step in QSAR analysis. The reduced
set of descriptors was then treated by forward stepwise vari-
able selection for further reduction of non-signiﬁcant descrip-
tors and ﬁnally the optimum models with ﬁve signiﬁcant
descriptors were considered in our 2D-QSAR analysis. The
variable/feature selection method can be used together with
MLR regression analysis for constructing a 2D-QSAR model.
The 2D-QSAR model was generated by using multiple linear
regression (MLR) method by using VLife Molecular DesignSuite (VLife MDS). MLR is the traditional and standard ap-
proach for multivariate data analysis. Multivariate analysis is
the analysis of multidimensional data metrics by using statisti-
cal methods. It relates the dependent variable (biological activ-
ity) to a number of independent (predictor) variables
(molecular descriptors) by using linear equations. This method
of regression estimates the values of the regression coefﬁcients
by applying least square curve ﬁtting method.
2.4.4. Statistical parameters for 2D-QSAR models
The program computes the best model on the basis of coefﬁ-
cient of determination/squared correlation coefﬁcient r2;
cross-validated correlation coefﬁcient/cross-validated ex-
plained variance q2, which is a relative measure of quality of
ﬁt; F-test (Fischer’s value) which represents F-ratio between
the variances of calculated and observed activity; pred_r2, r2
for external test set; DF, degree of freedom; Zscore, calculated
by q2 in the randomization test; best_rand_q2, the highest q2
value in the randomization test and alpha_rand_q2, the statis-
tical signiﬁcance parameter obtained by randomization test.
The coefﬁcient of determination/squared correlation coefﬁ-
cient r2 is a relative measure of ﬁt by the regression equation.
The coefﬁcient of determination is the percent of the variation
that can be explained by the regression equation. It represents
the explained variance of the model, and is used as a measure
of the goodness-of-ﬁt of the model. The correlation coefﬁcient
values closer to 1.0 represent the better ﬁt of the regression.
The F-test reﬂects the ratio of the variance explained by the
model and the variance due to the error in the regression. High
values of the F-test indicate that the model is statistically sig-
niﬁcant. Cross-validated correlation coefﬁcient/cross-validated
explained variance q2 is used as a measure of the internal per-
formance, and sometime used to estimate predictivity. Valida-
tion parameter, pred_r2 was calculated for evaluating the
predictive capacity of the model. A value of pred_r2 greater
than 0.5 indicates the good predictive capacity of the QSAR
model. However, a QSAR model is considered to be predic-
tive, if the following conditions are satisﬁed: r2 > 0.6,
q2 > 0.6 and pred_r2 > 0.5 (Golbraikh and Tropsha, 2002).
The low standard error of pred_r2se, q2se and r2se shows abso-
lute quality of ﬁtness of the model. The generated QSAR mod-
el was validated for predictive ability inside the model by using
cross validation (LOO) for q2 and external validation, which is
a more robust alternative method by dividing the data into
training set & test set and calculating pred_r2. The high
pred_r2 and low pred_r2se show high predictive ability of the
model.
2.5. Molecular modeling for 3D-QSAR
2.5.1. Molecular alignment
Proper alignment of molecules is the most critical input and a
crucial step in the ligand based 3D-QSAR modeling method to
obtain meaningful results (Tanneeru et al., 2011; Sharma and
Kohli, 2012). Molecular alignment is useful for studying shape
variation with respect to the base structure selected for align-
ment (VLife MDS 3.5, 2008). Energy-minimized and geome-
try-optimized structures of molecules were aligned by the
template-based method (Ajmani et al., 2006), where a template
structure is deﬁned and used as a basis for alignment of a set of
molecules. The template structure, i.e. 5-phenyl-1H-benzimid-
Figure 1 5-Phenyl-1H-benzimidazole ring as common template
used for alignment of benzimidazole derivatives.
Figure 2 Stereo view of template based alignment of benzimid-
azole derivatives on the base template.
S262 K.S. Bhadoriya et al.azole ring, was used for the alignment by considering the com-
mon elements of the series as shown in Fig. 1. The reference
molecule is chosen in such a way that it is the most active
among the series of molecules considered. The reference mole-
cule is the molecule on which the other molecules of the align
dataset get aligned based on the chosen template (VLife MDS
3.5, 2008). Compound 21 possessed very high inhibitory activ-
ity against cTRPM8 which made it is a valid lead molecule
and, therefore, was chosen as a reference molecule. After opti-
mizing, the template structure and the reference molecule were
used to superimpose all molecules from the series using the
template alignment method in VLife MDS 3.5 software (VLife
MDS 3.5, 2008) to obtain optimal alignment between the
molecular structures necessary for ligand–receptor interac-
tions. This adjusts the geometry of the molecules such that
their steric and electrostatic ﬁelds match the ﬁelds of the tem-
plate molecule (Radhika et al., 2010). The superimposition of
all molecules based on minimizing RMS deviation is shown in
Fig. 2.2.5.2. Molecular descriptors
MFA is a method for quantifying the interaction energy be-
tween a probe molecule and a set of aligned target molecules
in a rectangular grid box and can be useful in establishing
QSAR (Nakka and Guruprasad, 2012). This approach is effec-
tive for the analysis of data sets where activity information is
available but the structure of the receptor site is unknown. It
attempts to postulate and represent the essential features of a
receptor site from the aligned common features of the mole-
cules that bind to it (Sahu et al., 2011). The aligned biologically
active conformations of benzimidazole were used for the calcu-
lation of molecular ﬁelds. Molecular ﬁelds are the electrostatic,
steric and hydrophobic interaction energies which are used to
formulate a relationship among electrostatic, steric and hydro-
phobic properties together with the biological activities of
compounds. Each conformation is taken in turn and the
molecular ﬁelds around it are calculated. Molecular descrip-
tors such as steric, electrostatic and hydrophobic ﬁelds have
been calculated utilizing VLife MDS 3.5 software which allows
the user to choose probe, grid size, and grid interval for the
generation of descriptors (Ghosh and Bagchi, 2009). This is
done by generating 3D rectangular grids around the molecule
and calculating the interaction energy between the molecule
and probe group placed at each grid point. Using Tripos force
ﬁeld (Clark et al., 1989), steric, electrostatic and hydrophobic
ﬁelds were computed at each grid point considering Gastei-
ger-Marsili charges (Gasteiger and Marsili, 1980). Methyl
probe of charge + 1 with 10.0 kcal/mol electrostatic and
30.0 kcal/mol steric cut-off was used for ﬁeld generation. A va-
lue of 1.0 was assigned to the distance-dependent dielectric
constant. A total of 3432 three dimensional descriptors were
calculated using VLife MDS software. These included electro-
static, steric and hydrophobic ﬁeld descriptors (1144 for each
electrostatic, steric & hydrophobic) for all the compounds in
separate columns. These interaction energy values at the grid
point are considered for relationship generation using kNN
method and utilized as descriptors to decide nearness between
molecules (Ajmani et al., 2006).
2.5.3. Division of a dataset into training and test sets
The sphere exclusion algorithm (Golbraikh and Tropsha,
2003) was adopted for division of training and test data sets.
This algorithm allows construction of the data sets by using
descriptor space occupied by the representative points, such
that the test set compounds represent a range of biological
activities similar to the training set; thus, the test set is truly
a representative of the training set. In order to assess the sim-
ilarity of the distribution pattern of the compounds in the gen-
erated sets, statistical parameters (with respect to the biological
activity) i.e. mean, maximum, minimum and standard devia-
tion were calculated for the training and test sets. For selection
of training and test sets, we were ensured that the compounds
have uniform spread (training and test) in terms of both activ-
ity and chemical space. This was achieved by setting aside four
compounds as test set. Sphere exclusion approach resulted in
the selection of compounds 11, 15, 19 and 20 as the test set
for validating the quality of the models and the remaining 21
compounds as the training set for generating 3D-QSAR mod-
els. The test was used to ascertain the predictive power of the
model.
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Feature selection is a key step in QSAR analysis. Chance cor-
relations and multi-collinearity are two major problems often
encountered when attempting to ﬁnd generalized QSAR mod-
els for use in drug design. An integral aspect of any model-
building exercise is the selection of an appropriate set of
features with low complexity and good predictive accuracy.
This process forms the basis of a technique known as feature
selection or variable selection. Among several search algo-
rithms, stepwise (SW), genetic algorithm (GA) and simulated
annealing (SA) based feature selection procedures are most
popular for building QSAR models and can explain the situa-
tion more effectively (Guyon and Elisseeff, 2003; Darlington,
1990; Zheng and Tropsha, 2000). In SW forward variable
selection algorithm, the search procedure begins with develop-
ing a trial model step by step with a single independent vari-
able and to each step, independent variables are added one
at a time, examining the ﬁt of the model by using the kNN-
MFA procedure. Thus, the model is repeatedly altered from
the previous one by adding or removing a predictor variable
in accordance with the ‘stepping criteria’ (in this case, F= 4
for inclusion for the forward selection method). The method
continues until there is no more signiﬁcant variable remaining
outside the model.
In the selected equations, the cross-correlation limit was set
at 0.5, the number of variables at 10 and the term selection cri-
teria at r2. An F value was speciﬁed to evaluate the signiﬁcance
of a variable. The variance cut-off was set at 0.0, and scaling as
none. Additionally kNN parameter setting was done in which
the number of maximum neighbors and the number of mini-
mum neighbors were set at 5 & 2 respectively and the predic-
tion method was selected as the distance-based weighted
average.
2.5.5. kNN-MFA methodology for building QSAR models
The kNN technique is a conceptually simple approach to pat-
tern recognition problems (VLife MDS 3.5, 2008). The k-near-
est neighbor (kNN) method is one of the simplest machine
learning algorithms, most commonly used for classifying a
new pattern (e.g. a molecule) (Verma et al., 2010). The kNN
methodology relies on a simple distance learning approach
whereby an unknown member is classiﬁed according to the
majority of its k-nearest neighbors in the training set.
The nearness is measured by an appropriate distance metric
(e.g., a molecular similarity measure calculated using ﬁeld
interactions of molecular structures). The standard kNN meth-
od is implemented simply as follows: (1) Calculate the dis-
tances between an unknown object (u) & all the objects in
the training set; (2) Select k objects from the training set most
similar to object u, according to the calculated distances; and
(3) Classify object u with the group to which the majority of
the k objects belongs (Sharaf et al., 1986). An optimal k value
is selected by optimization through the classiﬁcation of a test
set of samples or by leave-one-out cross-validation. The vari-
ables & optimal k values were chosen using stepwise variable
selection method. kNN-MFA with stepwise (SW) variable
selection method employs a stepwise variable selection proce-
dure combined with kNN to optimize (i) The number of near-
est neighbors (k) and (ii) The selection of variables from the
original pool.2.5.6. k-Nearest neighbor QSAR (kNN weighted average
method)
The kNN method was also used to develop a QSAR model
using continuous variable i.e. using activity as pIC50 values.
In this case, by using a developed kNN QSAR model the activ-
ity of a molecule can be predicted using weighted average
activity (Eq. (1)) of the k most similar molecules in the training
set.
y^i ¼
X
wiyi ð1Þ
where yi and y^i are the actual and predicted activity of the
ith molecule respectively, and wi are weights calculated using
(Eq. (2)).
wi ¼ expðdjÞPk
j¼1 expðdjÞ
ð2Þ
The similarities were evaluated as the inverse of Euclidean
distances (dj) between molecules (Eq. (3)) using only the subset
of descriptors corresponding to the model. Where, k is number
of nearest neighbors in the model.
dij ¼
Vn
PðXim  XjmÞ
 1=2
m ¼ 1
ð3Þ
where X is the matrix of selected descriptors (Vn) for the
kNN QSAR model.
2.5.7. Model validation and evaluation
This is done to test the internal stability and predictive ability
of the QSAR models.
2.5.7.1. Internal and external validations. Internal validation
was carried out using leave-one-out (q2, LOO) method (Cra-
mer et al., 1988). For calculating q2, each molecule in the train-
ing set was eliminated once and the activity of the eliminated
molecule was predicted by using the model developed by the
remaining molecules. The cross-validated coefﬁcient, q2, was
calculated using Eq. (4).
q2 ¼ 1
Pðyi  y^iÞ2Pðyi  ymeanÞ2
ð4Þ
where yi and y^i are the actual and the predicted activity
of the ith molecule in the training set, respectively, and
ymean is the average activity of all molecules in the training
set.
However, a high q2 value does not necessarily give a suit-
able representation of the real predictive power of the model
for cTRPM8 antagonists. So, an external validation is also car-
ried out in this study. The external predictive power of the
model is assessed by predicting pIC50 value of four test set
molecules, which are not included in the QSAR model devel-
opment. The predictive ability of the selected model is also
conﬁrmed by pred_r2.
For external validation, the activity of each molecule
in the test set was predicted using the model developed by
the training set. The pred_r2 value is calculated as follows
(Eq. (5))
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Pðyi  y^iÞ2Pðyi  ymeanÞ2
ð5Þ
where yi and y^i are the actual and the predicted activity of
the ith molecule in the test set, respectively, and ymean is the
average activity of all molecules in the training set.
Both summations are over all molecules in the test set. Thus
the pred_r2 value is indicative of the predictive power of the
current kNN-MFA model based on the external test set.
2.5.7.2. Randomization test. To evaluate the statistical signiﬁ-
cance of a QSAR model for an actual data set, one tail hypoth-
esis testing was used (Zheng and Tropsha, 2000; Gilbert, 1976).
The robustness of the models for training sets was examined by
comparing these models to those derived for random data sets.
Random sets were generated by rearranging the activities of
the molecules in the training set. The statistical model was de-
rived using various randomly rearranged activities (random
sets) with the selected descriptors and the corresponding q2
were calculated. The signiﬁcance of the models hence obtained
was derived based on the calculated Zscore; Eq. (6).
A Zscore value is calculated by the following formula:
Zscore ¼ ðh lÞ
r
ð6Þ
where h is the q2 value calculated for the actual data set, l is
the average q2, and r is its standard deviation calculated for var-
ious iterations usingmodels build by different randomdata sets.
The probability (a) of signiﬁcance of the randomization test
is derived by using calculated Zscore value as given in the lit-
erature (Shen et al., 2003).
2.5.7.3. Evaluation of the quantitative model. The developed
3D-QSAR model was evaluated using the following statistical
measures: N, number of observations (molecules) in the train-
ing set; Number of nearest neighbors, number of k-nearest
neighbor in the model; q2, cross-validated r2 (by leave one
out) which is a relative measure of quality of ﬁt; pred_r2, r2
for external test set; q2se, standard error of cross-validation
and pred_r2se, standard error of external test set prediction.
However, a QSAR model is considered to be predictive, if
the following conditions are satisﬁed: q2 > 0.6 and
pred_r2 > 0.5 (Golbraikh and Tropsha, 2002). The low stan-
dard error of pred_r2se and q2se shows absolute quality of ﬁt-
ness of the model. The high pred_r2 and low pred_r2se show
high predictive ability of the model.
The q2 and pred_r2 values were used as deciding factors in
selecting the optimal models.Table 2 Unicolumn statistics of the training and test sets for inhib
Data set Column name Average M
2D-QSAR
Training pIC50 8.6483 9
Test pIC50 8.5586 9
3D-QSAR
Training pIC50 8.5374 9
Test pIC50 9.0744 9
Max., maximum; Min., minimum; SD, standard deviation.3. Result and discussion
The 2D- and 3D-QSAR studies of 25 benzimidazole deriva-
tives for inhibitory activity against cTRPM8 (Table 1) through
MLR and kNN methodology, respectively, based on SW fea-
ture selection method were performed using VLife MDS 3.5
software (VLife MDS 3.5, 2008). Sphere exclusion method
was selected for the division of whole data set into training
and test sets (Table 1) for choosing uniformly distributed mol-
ecules in both sets. For selection of training and test sets, we
were ensured that the molecules have uniform spread (training
and test) in terms of both activity and chemical space. pIC50
was selected as dependent variable and remaining all the vari-
ables were selected as independent variables. Selection of com-
pounds in the training set and test set is a key and important
feature of any QSAR model. Therefore care was taken in such
a way that biological activities of all compounds in test lie
within the maximum and minimum value range of biological
activities of the training set of compounds. A unicolumn statis-
tics for training set and test set were generated to check cor-
rectness of selection criteria for training and test set
compounds (Table 2).
The maximum and minimum values in training and test sets
were compared in a way that:
1. The maximum value of pIC50 of the test set should be less
than or equal to the maximum value of pIC50 of the train-
ing set.
2. The minimum value of pIC50 of the test set should be higher
than or equal to the minimum value of pIC50 of the training
set.
This observation showed that the test set was interpolative
and derived within the minimum–maximum range of the train-
ing set.
Statistically signiﬁcant models were selected, considering the
term selection criterion as r2, q2 and pred_r2. The models were
validated by both internal and external validation procedures.
Best 2D- and 3D-QSAR models are chosen for discussion.
3.1. 2D-QSAR
The various 2D-QSAR models were developed using multiple
linear regression (MLR) method. 2D-QSAR equations were
selected by optimizing the statistical results generated along
with variation of the descriptors in these models. The ﬁtness/
pattern plots were also generated for evaluating the depen-itory activity against cTRPM8.
ax. Min. SD Sum
.7000 7.0400 0.5674 155.6700
.2200 7.2100 0.6550 59.9100
.6990 7.0410 0.5931 179.2864
.2218 8.9208 0.1383 36.2976
Exploring 2D and 3D QSARs of benzimidazole derivatives as transient receptor potential melastatin 8 (TRPM8) S265dence of the biological activity on various different types of the
descriptors. The frequency of use of a particular descriptor in
the population of equations indicated the relevant contribu-
tions of the descriptors.
The best regression equation obtained is represented in Eq.
(7):Table 3 Statistical results of 2D-QSAR equation generated by ML
variable selection kNN-MFA method for benzimidazole derivatives.
S. No. Statistical parameter Results
2D-QSA
1 r2 0.88
2 r2se 0.23
3 q2 0.64
4 q2se 0.41
5 pred_r2 0.69
6 pred_r2se 0.37
7 F-test 17.57
8 N 18
9 Nearest neighbor –
10 Degree of freedom 12
11 Zscore_q2 3.00144
12 best_rand_q2 0.47898
13 alpha_rand_q2 0.01000
14 Contributing descriptors 1. Polar
2. kapp
3. Xcom
4.+veP
5. XKM
Table 4 Selected physico-chemical descriptors used in 2D-QSAR m
Compound pIC50 Polarizability AHP kappa2 Xcom
1 7.21 41.039 8.1648 0.5
2 8.22 41.039 8.1648 0.5
3 8.51 41.039 8.1648 3.4
4 8.54 39.386 7.438017 4.3
5 8.96 41.676 8.741253 3.2
6 8.6 42.965 8.859375 2.3
7 7.04 41.63 7.796982 0.4
8 8.62 41.405 7.438017 3.2
9 8.1 45.619 8.1648 2.9
10 8.64 39.295 7.679584 3.1
11 9.22 40.948 8.408284 3.2
12 9.1 41.585 8.981844 0.5
13 8.66 40.948 8.408284 3.4
14 8.48 42.967 8.408284 4.7
15 9.15 43.025 8.981844 5.5
16 8.57 43.665 8.408284 3.4
17 8.77 40.948 8.408284 5.6
18 9.1 42.601 9.141498 5.9
19 8.92 43.238 9.707555 1.9
20 9 42.967 8.408284 4.9
21 9.7 47.181 10.16595 3.7
22 8.17 39.841 8.1648 1.9
23 9.05 40.857 8.340496 3.8
24 8.85 41.403 9.141498 4.0
25 8.4 41.769 8.408284 1.1pIC50 ¼ 5:40081 0:0509337 polarizabilityAHP
þ 0:757011kappa2 0:200476XcompDipole
 0:0100592 þvePotentialSurfaceArea
þ 2:11017XKMostHydrophilic ð7ÞR method and 3D-QSAR model generated by forward stepwise
R 3D-QSAR
–
–
0.81
0.26
0.55
0.43
–
21
5
18
–
–
–
izability AHP 1. E_1024 (0.3652, 0.3433)
a2 2. S_774 (0.1842, 0.1634)
pDipole
otential Surface Area
ost Hydrophilic
odel with values.
pDipole +vePotential Surface Area XKMost Hydrophilic
69695 247.668274 0.313501
69456 268.623474 0.518432
06923 290.065186 0.510254
36603 265.042358 0.45733
68443 254.273575 0.539697
79686 275.87738 0.507704
448 300.308105 0.491227
66764 215.876434 0.501297
82738 250.004211 0.468389
86778 254.287094 0.466665
77809 262.351349 0.524292
33051 222.778351 0.555079
64247 290.227386 0.530688
29369 287.389801 0.594294
93012 314.157806 0.467935
65478 283.43042 0.617796
61723 307.554199 0.556983
51039 321.074005 0.607054
97233 262.491089 0.641335
56248 290.760132 0.598902
60355 300.417053 0.469463
84283 215.499512 0.262306
13835 241.814011 0.53442
99267 281.497498 0.35867
56562 216.434906 0.344089
Table 5 Correlation matrix for physico-chemical descriptors inﬂuencing the inhibitory activity against cTRPM8 (2D-QSAR model).
Polarizability AHP kappa2 XcompDipole +vePotential surface area XKMost Hydrophilic Score
Polarizability AHP 1 0.61941 0.024815 0.298363 0.260522 5
kappa2 0.61941 1 0.007689 0.398268 0.172653 5
XcompDipole 0.024815 0.007689 1 0.442572 0.071619 5
+vePotential Surface Area 0.298363 0.398268 0.442572 1 0.470572 5
XKMost Hydrophilic 0.260522 0.172653 0.071619 0.470572 1 5
Figure 3 Fitness plot of observed activity (pIC50) versus
predicted activity (pIC50) for training set & test set compounds
according to 2D-QSAR MLR model.
S266 K.S. Bhadoriya et al.The equation explains 88% (r2 = 0.88) of the total variance in
the training set. It also has an internal (q2) and external
(pred_r2) predictive ability of 64% and 69% respectively.
The F-test = 17.57 shows the statistical signiﬁcance of
99.99% of the model which means that probability of failure
of the model is 1 in 10,000. In addition, the randomization test
shows conﬁdence of 99.9% that the generated model is not
random and hence it is chosen as the QSAR model (Table 3).
The descriptors selected for 2D-QSAR modeling inhibitory
activity against cTRPM8 of benzimidazole derivatives are
summarized in Table 4 and the correlation matrix between
the physico-chemical descriptors inﬂuencing the inhibitory
activity against cTRPM8 is presented in Table 5.
The ﬁtness plot of observed versus predicted activity
provides an idea about how well the model was trained
and how well it predicts the activity of the external test
set. From the ﬁtness plot it can be seen that the model is
able to predict the activity of training set quite well (all
points are close to regression line) as well as external test
set up to 69% (all points are close to regression line)
providing conﬁdence in predictive ability of the model
(Fig. 3). The predicted activities & residuals of both train-
ing & test set compounds by 2D-QSAR model are shown
in Table 6.3.1.1. Interpretation of 2D-QSAR MLR model
It is apparent from Equation (7) and Fig. 4 that the descriptor
kappa2 plays a pivotal role in determining activity. This
descriptor (kappa2) signiﬁes second kappa shape index. This
is a positively contributing descriptor toward inhibitory activ-
ity against cTRPM8 and its contribution is approx 34%
(Fig. 4). The positive coefﬁcient of kappa2 (33.70%) showed
that increase in the values of this descriptor is beneﬁcial for
the inhibitory activity against cTRPM8 (like in compounds
5, 12, 15, 18, 19, 21 and 24). The next important descriptor
which inﬂuences the activity is XcompDipole that signiﬁes
the x component of the dipole moment (external coordinates).
This descriptor is inversely proportional to the activity
(25.91%). The negative coefﬁcient of XcompDipole
(25.91%) showed that increase in the values of this descriptor
is detrimental for the inhibitory activity against cTRPM8 (like
in compounds 1, 2, 7, 15, 17, 18, 20, 21 and 24). The negative
coefﬁcient (21.17%) of +vePotentialSurfaceArea (signiﬁes
total van der Waals surface area with positive electrostatic po-
tential of the molecule) showed that increase in the values of
this descriptor is detrimental for the inhibitory activity against
cTRPM8 (like in compounds 5, 7, 8, 11, 12 and 23). As a po-
sitive contributing descriptor, XKMostHydrophilic (most
hydrophilic value on the vdW surface) is also a physico-
chemical descriptor inﬂuencing activity variation and is di-
rectly proportional to activity. The positive coefﬁcient of
XKMostHydrophilic (13.09%) showed that increase in the val-
ues of this descriptor is beneﬁcial for the inhibitory activity
against cTRPM8 (like in compounds 1, 5, 12, 13, 16, 17, 18,
19, 20, 22 and 23). The last descriptor is polarizabilityAHP
which is an individual descriptor that evaluates molecular
polarizability using atomic hybrid polarizability (AHP) and
negatively contributes to the biological activity (6.12%).
The negative coefﬁcient of polarizabilityAHP showed that in-
crease in the values of this descriptor is detrimental for the
inhibitory activity against cTRPM8 (like in compounds 5, 8,
9, 10, 11, 12, 13, 14, 17, 23 and 24).
3.2. 3D-QSAR
Three dimensional quantitative structure–activity relationship
studies of benzimidazole derivatives with reported activities
against cTRPM8 were performed using stepwise variable selec-
tion method for developing kNN-MFA models based on ste-
ric, electrostatic & hydrophobic ﬁelds. Several 3D-QSAR
models were generated using stepwise variable selection meth-
od resulted several statistically signiﬁcant models, of which the
corresponding best model is reported herein.
The model selection criterion is the value of q2, the internal
predictive ability of the model and that of pred_r2, the ability
of the model to predict the activity of external test set. For
Table 6 Comparative observed and predicted activities of benzimidazole derivatives by 2D and 3D-QSAR models.
Compound Observed activity (pIC50) 2D-QSAR model 3D-QSAR model
Predicted activity Residual Predicted activity Residual
1 7.21 7.7758 0.5658 7.04096 0.16904
2 8.22 7.99739 0.22261 8.50864 0.28864
3 8.51 8.3333 0.1767 8.22185 0.28815
4 8.54 8.19372 0.34628 8.63827 0.09827
5 8.96 9.13163 0.17163 9.09691 0.13691
6 8.6 8.6924 0.0924 8.48149 0.11851
7 7.04 7.28773 0.24773 7.21467 0.17467
8 8.62 8.46375 0.15625 8.95861 0.33861
9 8.1 8.32962 0.22962 8.60206 0.50206
10 8.64 8.2786 0.3614 8.5376 0.1024
11 9.22 8.80477 0.41523 8.56864 0.65136
12 9.1 9.11929 0.01929 9.09691 0.00309
13 8.66 8.57523 0.08477 8.56864 0.09136
14 8.48 8.88879 0.40879 8.56864 0.08864
15 9.15 8.95726 0.19274 8.95861 0.19139
16 8.57 8.68928 0.11928 8.65758 0.08758
17 8.77 8.89697 0.12697 9.09691 0.32691
18 9.1 9.39548 0.29548 9.09691 0.00309
19 8.92 8.85975 0.06025 8.65758 0.26242
20 9 8.91009 0.08991 9.09691 0.09691
21 9.7 9.416 0.284 9.09691 0.60309
22 8.17 8.33597 0.16597 8.39794 0.22794
23 9.05 9.09351 0.04351 8.85387 0.19613
24 8.85 8.95924 0.10924 8.60206 0.24794
25 8.4 8.41931 0.01931 8.17393 0.22607
Figure 4 Contribution of descriptors for biological activity
developed using MLR equation.
Figure 5 Fitness plot of observed activity (pIC50) versus
predicted activity (pIC50) for training set & test set compounds
according to 3D-QSAR SW-kNN-MFA model.
Exploring 2D and 3D QSARs of benzimidazole derivatives as transient receptor potential melastatin 8 (TRPM8) S267inhibitory activity against cTRPM8, selected the template-
based 3D-QSAR model with 21 training set compounds was
found to be statistically most signiﬁcant, especially with re-
spect to the internal predictive ability (q2 = 0.81) of the model.
As the cross-validated correlation coefﬁcient (q2) is used as a
measure of reliability of prediction, the correlation coefﬁcient
suggests that our model is reliable and accurate. The LOO
cross-validated analysis of the best model gave rise to a q2 va-
lue of 0.81 suggesting that the model is a useful tool for pre-
dicting inhibitory activity against cTRPM8. A data set of
four compounds was selected as the test set from the originaldata of 25 compounds for the validation experiments. The
predictive ability of this forward stepwise variable selection
kNN-MFA model was evaluated by predicting the biological
activities of the test set compounds. Residual values obtained
by subtraction of predicted activities from biological activities
were found near to zero. Therefore it was concluded that the
Table 7 Descriptors used in 3D-QSAR model with values.
Compound pIC50 E_1024 S_774
1 7.21 0.2339 0.208062
2 8.22 0.16111 0.171235
3 8.51 0.191864 0.142129
4 8.54 0.377701 0.173954
5 8.96 0.364871 0.174306
6 8.6 0.413408 0.154159
7 7.04 0.26824 0.141407
8 8.62 0.365198 0.163383
9 8.1 0.446816 0.17988
10 8.64 0.377819 0.173457
11 9.22 0.414777 0.178667
12 9.1 0.348411 0.18209
13 8.66 0.391136 0.179788
14 8.48 0.392356 0.175788
15 9.15 0.366994 0.180889
16 8.57 0.39333 0.17858
17 8.77 0.343279 0.166872
18 9.1 0.357838 0.184159
19 8.92 0.386703 0.190586
20 9 0.320989 0.175561
21 9.7 0.327277 0.167751
22 8.17 0.42539 0.239621
23 9.05 0.660477 0.664457
24 8.85 0.386963 0.032763
25 8.4 0.412358 0.241024
Table 8 Correlation matrix for electrostatic and steric
descriptors inﬂuencing the inhibitory activity against cTRPM8
(3D-QSAR model).
E_1024 S_774 Score
E_1024 1 0.311113 2
S_774 0.311113 1 2
Figure 6 Developed 3D-QSAR SW-kNN-MFA model ﬁeld plot
for steric and electrostatic interactions of all 25 compounds.
S268 K.S. Bhadoriya et al.resultant QSAR model has good predictive ability. The value
of pred_r2 was obtained for the test set and gave better results,
with a value of 0.55, which means 55% predictive power forthe external test set. Thus, our model displays good predictiv-
ity in regular cross-validation (Table 3). The actual, predicted
activities by 3D-QSAR model & residuals of both training &
test set compounds are given in Table 6. The ﬁtness plot of ob-
served versus predicted activity of both training & test set com-
pounds helped in cross-validation of kNN-MFA 3D-QSAR
model and are depicted in Fig. 5.
The descriptors selected for 3D-QSAR modeling inhibitory
activity against cTRPM8 of benzimidazole derivatives are
summarized in Table 7 and the correlation matrix between
the electrostatic and steric descriptors inﬂuencing the inhibi-
tory activity against cTRPM8 is presented in Table 8.
The plot of contributions of steric and electrostatic ﬁeld
interactions (Fig. 6) indicates relative regions of the local ﬁelds
(steric and electrostatic ﬁelds) around the aligned molecules.
Green and blue balls represent steric and electrostatic ﬁeld ef-
fects, respectively.
In 3D-QSAR studies, 3D data points generated around
benzimidazole pharmacophore were used to optimize the elec-
trostatic & steric requirements of the benzimidazole nucleus
for inhibitory activity against cTRPM8. The range of property
values in the generated data points helped for the design of
new chemical entities. These ranges were based on the varia-
tion of the ﬁeld values at the chosen points using the most ac-
tive molecule & its nearest neighbor set. The points generated
in SW-kNN-MFA 3D-QSAR model are S_774 (0.1842,
0.1634) and E_1024 (0.3652, 0.3433) that is steric & elec-
trostatic interaction ﬁelds at lattice points 774 & 1024 respec-
tively (Fig. 6). These points suggested the signiﬁcance and
requirement of steric & electrostatic properties as mentioned
in the ranges in parenthesis for SAR & maximum biological
activities of benzimidazole analogs.
From 3D-QSAR model, it is observed that negative values
in steric ﬁeld descriptor indicated the requirement of negative
steric potential for enhancing the biological activity of benz-
imidazole analogs. Therefore less steric substituents were pre-
ferred at the position of generated data points S_774
(0.1842, 0.1634) around benzimidazole pharmacophore.
Similarly the negative values of electrostatic descriptors sug-
gested the requirement of electronegative groups like NO2,
SO2R, CN, SO2Ar, COOH, F, Cl, Br, I, COOR, OR, OH
etc. at the position of generated data point E_1024 (0.3652,
0.3433) around benzimidazole pharmacophore for maximum
activity.
Two data points generated at the position of R2 around
benzimidazole nucleus were steric point S_774 (0.1842,
0.1634) and electrostatic point E_1024 (0.3652, 0.3433).
These points may show requirement of less steric substituents
containing electronegative groups.
4. Conclusion
The present study elucidates key structural requirements for
the inhibitory activity against cTRPM8 utilizing 2D and 3D-
QSAR models. This work reveals how the inhibitory activities
against cTRPM8 of various benzimidazole derivatives may be
treated statistically to uncover the molecular characteristics
which are essential for high activity. The 2D- and 3D-QSAR
studies have been carried out on a series of benzimidazole
derivatives against cTRPM8. Both 2D- and 3D-QSAR models
are statistically signiﬁcant. The 2D-QSAR model obtained by
Exploring 2D and 3D QSARs of benzimidazole derivatives as transient receptor potential melastatin 8 (TRPM8) S269SW-MLR method indicates that increase in kappa2 and
XKMostHydrophilic or decrease in XcompDipole,+vePoten-
tialSurfaceArea and polarizabilityAHP values of benzimid-
azole derivatives leads to increases in potency of molecules
(pIC50). The 3D results reveal that less bulky substituents with
electronegative groups at R2 position of benzimidazole ring are
required for potent cTRPM8 antagonists. A combination of
the above models is useful in understanding the structural
requirements for design of novel, potent and selective
cTRPM8 antagonists. Reliability of the models was conﬁrmed
by several statistical analyses and thus, the proposed models,
due to the good predictive ability, offer a useful alternative
for determining inhibitory activity against cTRPM8 of newly
designed molecules. These efforts will guide synthetic medici-
nal chemists to design and synthesize new compounds with
an increased biological activity in comparison to the reported
compounds.Acknowledgements
The authors gratefully acknowledge the ‘‘Department of Sci-
ence and Technology, Govt. of India’’ for providing funding
to institute for VLife MDS software. Authors like to acknowl-
edge Principal of the institute for providing facilities to carry
out the work. The authors also thank the anonymous review-
ers whose valuable comments and suggestions greatly helped in
improving the manuscript.
References
ACD/Chemsketch 12.0, 2009.
Ajmani, S., Jadhav, K., Kulkarni, S.A., 2006. Three-dimensional
QSAR using the k-nearest neighbor method and its interpretation.
J. Chem. Inf. Model. 46, 24–31.
Behrendt, H.-J., Germann, T., Gillen, C., Hatt, H., Jostock, R., 2004.
Characterization of the mouse cold-menthol receptor TRPM8 and
vanilloid receptor type-1 VR1 using a ﬂuorometric imaging plate
reader (FLIPR) assay. Br. J. Pharmacol. 141, 737–745.
Bhadoriya, K.S., Jain, S.V., Bari, S.B., Chavhan, M.L., Vispute, K.R.,
2012a. 3D-QSAR study of indol-2-yl ethanones derivatives as novel
indoleamine 2,3-dioxygenase (IDO) inhibitors. J. Chem. 9, 1753–
1759. http://dx.doi.org/10.1155/2012/368617.
Bhadoriya, K.S., Sharma, M.C., Jain, S.V., Raut, G.S., Rananaware,
J.R., 2012b. Three-dimensional quantitative structure–activity
relationship (3D-QSAR) analysis and molecular docking-based
combined in silico rational approach to design potent and novel
TRPV1 antagonists. Med. Chem. Res.. http://dx.doi.org/10.1007/
s00044-012-0226-4.
Clark, M., Cramer III, R.D., Van, O.N., 1989. Validation of the
general purpose Tripose 5.2 force ﬁeld. J. Comput. Chem. 10, 982–
1012.
Cramer III, R.D., Patterson, D.E., Bunce, J.D., 1988. Comparative
molecular ﬁeld analysis (CoMFA) 1. Effect of shape on binding of
steroids to carrier proteins. J. Am. Chem. Soc. 110, 5959–5967.
Darlington, R.B., 1990. Regression and Linear Models. McGraw-Hill,
New York.
Doweyko, A.M., 2008. QSAR: dead or alive? J. Comput. Aided Mol.
Des. 22, 81–89.
Flockerzi, V., 2007. An introduction on TRP channels. HEP 179, 1–19.
Ford, A.C., Talley, N.J., Spiegel, B.M.R., Foxx-Orenstein, A.E.,
Schiller, L., Quigley, E.M.M., Moayyedi, P., 2008. Effect of ﬁbre,
antispasmodics, and peppermint oil in the treatment of irritable
bowel syndrome: systematic review and meta-analysis. BMJ 337,
a2313. http://dx.doi.org/10.1136/bmj.a2313.Gasteiger, J., Marsili, M., 1980. Iterative partial equalization of orbital
electronegativity––a rapid access to atomic charges. Tetrahedron
36, 3219–3228.
Gaurav, A., Yadav, M.R., Giridhar, R., Gautam, V., Singh, R., 2010.
3D-QSAR studies of 4-quinolone derivatives as high-afﬁnity
ligands at the benzodiazepine site of brain GABAA receptors.
Med. Chem. Res.. http://dx.doi.org/10.1007/s00044-010-9306-5.
Ghosh, P., Bagchi, M.C., 2009. QSAR modeling for quinoxaline
derivatives using genetic algorithm and simulated annealing based
feature selection. Curr. Med. Chem. 16, 4032–4048.
Gilbert, N., 1976. Statistics. W.B. Saunders Co., Philadelphia, PA.
Golbraikh, A., Tropsha, A., 2002. Beware of q2! J. Mol. Graph.
Model. 20, 269–276.
Golbraikh, A., Tropsha, A., 2003. QSAR modeling using chirality
descriptors derived from molecular topology. J. Chem. Inf.
Comput. Sci. 43, 144–154.
Guyon, I., Elisseeff, A., 2003. An introduction to variable and feature
selection. J. Mach. Learn. Res. 3, 1157–1182.
Halgren, T.A., 1996a. Merck molecular force ﬁeld. II. MMFF94 van
der Waals and electrostatic parameters for intermolecular interac-
tions. J. Comp. Chem. 17, 520–552.
Halgren, T.A., 1996b. Merck molecular force ﬁeld. III. Molecular
geometries and vibrational frequencies. J. Comp. Chem. 17, 553–
586.
Halgren, T.A., 1996c. Merck molecular force ﬁeld. V.
Extension of MMFF94 using experimental data, additional
computational data and empirical rules. J. Comp. Chem. 17,
616–641.
Halgren, T.A., 1996d. Merck molecular force ﬁeld: I. Basis, form,
scope, parameterization and performance of MMFF94. J. Comp.
Chem. 17, 490–519.
Halgren, T.A., 1999a. MMFF VI. MMFF94s option for energy
minimization studies. J. Comp. Chem. 20, 720–729.
Halgren, T.A., 1999b. MMFF VII. Characterization of MMFF94,
MMFF94s, and other widely available force ﬁelds for conforma-
tional energies and for intermolecular-interaction energies and
geometries. J. Comp. Chem. 20, 730–748.
Hansch, C., 1969. A quantitative approach to biochemical structure–
activity relationships. Acc. Chem. Res. 2, 232–239.
Hayashi, T., Kondo, T., Ishimatsu, M., Yamada, S., Nakamura, K.,
Matsuoka, K., Akasu, T., 2009. Expression of the TRPM8-
immunoreactivity in dorsal root ganglion neurons innervating the
rat urinary bladder. Neurosci. Res. 65, 245–251.
Jain, S.V., Bhadoriya, K.S., Bari, S.B., 2012a. QSAR and ﬂexible
docking studies of some aldose reductase inhibitors obtained from
natural origin. Med. Chem. Res. 21, 1665–1676. http://dx.doi.org/
10.1007/s00044-011-9681-6.
Jain, S.V., Bhadoriya, K.S., Bari, S.B., Sahu, N.K., Ghate, M., 2012b.
Discovery of potent anticonvulsant ligands as dual NMDA and
AMPA receptors antagonists by molecular modelling studies. Med.
Chem. Res. 21, 3465–3484. http://dx.doi.org/10.1007/s00044-011-
9889-5.
Jain, S.V., Ghate, M., Bhadoriya, K.S., Bari, S.B., Chaudhari, A.,
Borse, J.S., 2012c. 2D, 3D-QSAR and docking studies of 1,2,3-
thiadiazole thioacetanilides analogues as potent HIV-1 non-nucle-
oside reverse transcriptase inhibitors. Org. Med. Chem. Lett. 2, 22.
http://dx.doi.org/10.1186/2191-2858-2-22.
Klein, A.H., Sawyer, C.M., Carstens, M.I., Tsagareli, M.G., Tsiklauri,
N., Carstens, E., 2010. Topical application of L-menthol induces
heat analgesia, mechanical allodynia, and a biphasic effect on cold
sensitivity in rats. Behav. Brain Res. 212, 179–186.
Mahieu, F., Owsianik, G., Verbert, L., Janssens, A., De Smedt, H.,
Nilius, B., Voets, T., 2007. TRPM8-independent Menthol-induced
Ca2+ release from endoplasmic reticulum and golgi. J. Biol. Chem.
282, 3325–3336.
McKemy, D.D., Neuhausser, W.M., Julius, D., 2002. Identiﬁcation of
a cold receptor reveals a general role for TRP channels in
thermosensation. Nature 416, 52–58.
S270 K.S. Bhadoriya et al.Merat, S., Khalili, S., Mostajabi, P., Ghorbani, A., Ansari, R.,
Malekzadeh, R., 2010. The effect of enteric-coated, delayed-release
peppermint oil on irritable bowel syndrome. Dig. Dis. Sci. 55,
1385–1390.
Metropolis, N., Rosenbluth, A.W., Rosenbluth, M.N., Teller, A.H.,
Teller, E., 1953. Equation of state calculations by fast computing
machines. J. Chem. Phys. 21, 1087–1092.
Nakka, S., Guruprasad, L., 2012. The imidazolidone analogs as
phospholipase D1 inhibitors: analysis of the three-dimensional
quantitative structure–activity relationship. Med. Chem. Res. 21,
2517–2525. http://dx.doi.org/10.1007/s00044-011-9773-3.
Parks, D.J., Parsons, W.H., Colburn, R.W., Meegalla, S.K., Ballen-
tine, S.K., Illig, C.R., Qin, N., Liu, Y., Hutchinson, T.L., Lubin,
M.L., Stone Jr., D.J., Baker, J.F., Schneider, C.R., Ma, J.,
Damiano, B.P., Flores, C.M., Player, M.R., 2011. Design and
optimization of benzimidazole-containing transient receptor poten-
tial melastatin 8 (TRPM8) antagonists. J. Med. Chem. 54, 233–247.
Peier, A.M., Moqrich, A., Hergarden, A.C., Reeve, A.J., Andersson,
D.A., Story, G.M., Earley, T.J., Dragoni, I., McIntyre, P., Bevan,
S., Patapoutian, A., 2002. A TRP channel that senses cold stimuli
and menthol. Cell 108, 705–715.
Radhika, V., Kanth, S.S., Vijjulatha, M., 2010. CoMFA and CoMSIA
studies on inhibitors of HIV-1 integrase-bicyclic pyrimidinones. J.
Chem. 7 (S1), S75–S84.
Rohacs, T., Lopes, C.M.B., Michailidis, I., Logothetis, D.E., 2005.
PI(4,5)P2 regulates the activation and desensitization of TRPM8
channels through the TRP domain. Nat. Neurosci. 8, 626–634.
Sabnis, A.S., 2007. Expression and characterization of TRPM 8
receptors in lung epithelial cells. University of Utah Spencer S.
Eccles Health Sciences Library, pp. 1–159.
Sabnis, A.S., Shadid, M., Yost, G.S., Reilly, C.A., 2008. Human lung
epithelial cells express a functional cold-sensing TRPM8 variant.
Am. J. Respir. Cell Mol. Biol. 39, 466–474.
Sahu, N.K., Bari, S.B., Kohli, D.V., 2011. Molecular modeling studies
of some substituted chalcone derivatives as cysteine protease
inhibitors. Med. Chem. Res.. http://dx.doi.org/10.1007/s00044-
011-9900-1.
Scior, T., Medina-Franco, J.L., Do, Q.T., Martinez-Mayorga, K.,
Yunes Rojas, J.A., Bernard, P., 2009. How to recognize and
workaround pitfalls in QSAR studies: a critical review. Curr. Med.
Chem. 16, 4297–4313.
Sharaf, M.A., Illman, D.L., Kowalski, B.R., 1986. Chemometrics,
Chemical Analysis Series. Wiley, New York.
Sharma, M.C., Kohli, D.V., 2012. A comprehensive structure–activity
analysis 2,3,5-trisubstituted 4,5-dihydro-4-oxo-3H-imidazo [4,5-c]
pyridine derivatives as angiotensin II receptor antagonists: using2D- and 3D-QSAR approach. Med. Chem. Res.. http://dx.doi.org/
10.1007/s00044-012-0040-z.
Shen, M., Xiao, Y., Golbraikh, A., Gombar, V.K., Tropsha, A., 2003.
An in silico screen for human S9 metabolic turnover using k-
nearest neighbor QSPR method. J. Med. Chem. 46, 3013–3020.
Sherkheli, M.A. et al., 2007. Selective TRPM8 agonists: a novel group
of neuropathic analgesics. FEBS J. 274 (s1), 232. http://dx.doi.org/
10.1111/j.0014-2956.2007.05861_4.x.
Sherkheli, M.A., Gisselmann, G., Vogt-Eisele, A.K., Doerner, J.F.,
Hatt, H., 2008. Menthol derivative WS-12 selectively activates
transient receptor potential melastatin-8 (TRPM8) ion channels.
Pak. J. Pharm. Sci. 21, 370–378.
Tanneeru, K., Reddy, B.M., Guruprasad, L., 2011. Three-dimensional
quantitative structure–activity relationship (3D-QSAR) analysis
and molecular docking of ATP-competitive triazine analogs of
human mTOR inhibitors. Med. Chem. Res.. http://dx.doi.org/
10.1007/s00044-011-9629-x.
Tsavaler, L., Shapero, M.H., Morkowski, S., Laus, R., 2001. Trp-p8, a
novel prostate-speciﬁc gene, is up-regulated in prostate cancer and
other malignancies and shares high homology with transient
receptor potential calcium channel proteins. Cancer Res. 61,
3760–3769.
Tsukimi, Y., Mizuyachi, K., Yamasaki, T., Niki, T., Hayashi, F., 2005.
Cold response of the bladder in guinea pig: involvement of
transient receptor potential channel, TRPM8. Urology 65, 406–
410.
Verma, J., Khedkar, V.M., Coutinho, E.C., 2010. 3D-QSAR in drug
design – a review. Curr. Top. Med. Chem. 10, 95–115.
VLife MDS 3.5, 2008. Molecular Design Suite. Vlife Sciences
Technologies Pvt. Ltd., Pune, India. <http://
www.vlifesciences.com>.
Voets, T., Droogmans, G., Wissenbach, U., Janssens, A., Flockerzi,
V., Nilius, B., 2004. The principle of temperature-dependent gating
in cold- and heat-sensitive TRP channels. Nature 430,
748–754.
Voets, T., Owsianik, G., Nilius, B., 2007. TRPM8. HEP 179,
329–344.
Zhao, H., Sprunger, L.K., Simasko, S.M., 2010. Expression of
transient receptor potential channels and two-pore potassium
channels in subtypes of vagal afferent neurons in rat. Am. J.
Physiol. Gastrointest. Liver Physiol. 298, G212–221.
Zheng, W., Tropsha, A., 2000. Novel variable selection quantitative
structure–property relationship approach based on the k-nearest
neighbor principle. J. Chem. Inf. Comput. Sci. 40, 185–194.
